GM Advisory Group, Inc.
- SEC CIK
- 0001598304
- Latest filing
- Apr 28, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by GM Advisory Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q1 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −1,631−100.0% | Sold out | Holders |
| Q1 2023 | 1,631 | $250.5K | <0.1% | −50−3.0% | Reduced | Holders |
| Q4 2022 | 1,681 | $301.9K | <0.1% | +1,681 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,650−100.0% | Sold out | Holders |
| Q2 2022 | 1,650 | $236.0K | <0.1% | +1,650 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −1,213−100.0% | Sold out | Holders |
| Q4 2021 | 1,213 | $308.0K | <0.1% | −40−3.2% | Reduced | Holders |
| Q3 2021 | 1,253 | $482.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,253 | $294.0K | <0.1% | −847−40.3% | Reduced | Holders |
| Q1 2021 | 2,100 | $275.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.